Ulrika Mattsson

Ulrika Mattsson serves as the Global Development Medical Director at AstraZeneca, specializing as a Study Clinical Lead in Late Phase CVRM with a focus on pediatric drug development. Mattsson has a history of leadership roles, including serving as Chairman of the Board for Nordvästra Götalands Läkarförening and as a Senior Pediatric Consultant at NU-sjukvården. Mattsson is the founder of Docum AB, a medical consulting firm, and actively participates in various committees, such as the Children’s Medicines Working Party for the EFGCP and the Election Preparation Committee for the Swedish Medical Association. Recent educational pursuits include a postgraduate degree in Pharmaceutical Sciences at the University of Basel and several leadership programs.